$221 Million is the total value of KNOTT DAVID M's 145 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 41.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PFE | Sell | Pfizer Inc. | $4,413,000 | -8.8% | 119,900 | -9.1% | 2.00% | -29.7% |
| LKQ | Sell | LKQ Corporation | $4,229,000 | +1.7% | 120,000 | -20.0% | 1.91% | -21.6% |
| ABBV | Sell | AbbVie Inc. | $3,511,000 | +6.1% | 32,769 | -13.2% | 1.59% | -18.1% |
| Sell | Trillium Therapeutics Inc. | $2,570,000 | +2.6% | 174,699 | -0.9% | 1.16% | -20.8% | |
| JPM | Sell | JP Morgan Chase | $2,538,000 | +14.4% | 19,970 | -13.4% | 1.15% | -11.8% |
| ALXN | Sell | Alexion Pharamaceuticals, Inc. | $1,648,000 | +20.0% | 10,545 | -12.1% | 0.75% | -7.4% |
| BCRX | Sell | BioCryst Pharmaceuticals, Inc. | $1,635,000 | +19.8% | 219,461 | -44.8% | 0.74% | -7.6% |
| BDSI | Sell | BioDelivery Sciences International, Inc. | $1,555,000 | -13.5% | 370,230 | -23.2% | 0.70% | -33.3% |
| JNJ | Sell | Johnson & Johnson | $956,000 | -11.8% | 6,080 | -16.5% | 0.43% | -31.9% |
| CNQ | Sell | Canadian Natural Resources Inc. | $536,000 | +4.5% | 22,285 | -30.4% | 0.24% | -19.3% |
| RDUS | Sell | Radius Health Inc. | $447,000 | -18.0% | 25,034 | -47.9% | 0.20% | -36.9% |
| FGEN | Sell | FibroGen, Inc. | $371,000 | -54.3% | 10,000 | -49.3% | 0.17% | -64.7% |
| AAPL | Sell | Apple Inc. | $279,000 | -42.6% | 2,100 | -50.0% | 0.13% | -55.8% |
| ADMA | Sell | ADMA Biologics, Inc. | $42,000 | -73.1% | 21,457 | -67.1% | 0.02% | -79.3% |
| CRDF | Exit | Cardiff Oncology, Inc. | $0 | – | -5,000 | -100.0% | -0.04% | – |
| KRYS | Exit | Krystal Biotech, Inc. | $0 | – | -7,079 | -100.0% | -0.18% | – |
| CYTK | Exit | Cytokinetics, Incorporated | $0 | – | -15,837 | -100.0% | -0.20% | – |
| CCXI | Exit | ChemoCentryx, Inc. | $0 | – | -6,587 | -100.0% | -0.21% | – |
| ALIM | Exit | Alimera Sciences, Inc. | $0 | – | -80,194 | -100.0% | -0.23% | – |
| COLL | Exit | Collegium Pharmaceutical, Inc. | $0 | – | -29,862 | -100.0% | -0.36% | – |
| ALKS | Exit | Alkermes PLC | $0 | – | -38,000 | -100.0% | -0.37% | – |
| SBBP | Exit | Strongbridge Biopharma PLC | $0 | – | -372,000 | -100.0% | -0.46% | – |
| FSK | Exit | FS KKR Capital Corp. | $0 | – | -395,175 | -100.0% | -3.68% | – |
| SRCL | Exit | Stericycle, Inc. | $0 | – | -160,000 | -100.0% | -5.92% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Ligand Pharmaceuticals Incorporated | 34 | Q3 2021 | 52.6% |
| Pfizer Inc. | 34 | Q3 2021 | 17.4% |
| Capitol Federal S&L | 34 | Q3 2021 | 5.7% |
| JP Morgan Chase& Co. | 34 | Q3 2021 | 1.3% |
| Apple Inc. | 34 | Q3 2021 | 2.1% |
| Microsoft Corporation | 34 | Q3 2021 | 2.3% |
| AllianceBernstein Holdings PL Unit Ltd. | 34 | Q3 2021 | 0.9% |
| Johnson & Johnson | 34 | Q3 2021 | 0.6% |
| Mondelez Int'lt Inc. | 34 | Q3 2021 | 0.5% |
| Ryman Hospitality PPTYS Inc. | 34 | Q3 2021 | 0.4% |
View KNOTT DAVID M's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| LIGAND PHARMACEUTICALS INC | February 13, 2018 | 865,500 | 4.1% |
| Rand Logistics, Inc. | November 15, 2017 | 1,432,660 | 7.2% |
| Essex Rental Corp. | August 16, 2013 | 1,124,472 | 4.5% |
| Westway Group, Inc. | February 01, 2013 | ? | ? |
| FutureFuel Corp. | February 01, 2012 | 1,838,000 | 4.5% |
| COLUMBIA LABORATORIES INC | January 31, 2012 | ? | ? |
| Essex Rental Corp. | February 16, 2011 | 2,805,666 | 13.0% |
| Pet DRx CORPSold out | February 09, 2011 | 0 | 0.0% |
| China Ceramics Co., Ltd | October 14, 2010 | 1,350,000 | 10.3% |
| NABI BIOPHARMACEUTICALS | June 22, 2010 | 2,344,597 | 4.8% |
View KNOTT DAVID M's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2021-11-12 |
| 13F-HR | 2021-08-13 |
| 13F-HR | 2021-05-13 |
| 13F-HR | 2021-02-12 |
| 13F-HR | 2020-11-13 |
| 13F-HR | 2020-08-12 |
| 13F-HR | 2020-05-13 |
| 13F-HR | 2020-02-14 |
| 13F-HR | 2019-11-12 |
| 13F-HR | 2019-08-12 |
View KNOTT DAVID M's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.